Clinical Validation of the Point-of-Care MSD Influenza Test

Stopped early

Conditions studied: Influenza Human

In brief

The primary objective of this study is to evaluate the performance of the MSD® Influenza Test in detecting influenza A and influenza B in subjects presenting with influenza-like-illness (ILI).

Key facts

Study ID

NCT00863343

Run by

Meso Scale Diagnostics, LLC.

People needed

391

Starts

2010-03-01

Expected to finish

2010-08-01

Last updated by the study team

2012-03-01

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Any subject (all ages) presenting with ILI (defined as fever [subjective or documented] and cough or sore throat), and suspected of having influenza.
• Subject (parent, guardian, or authorized legal representative) gives informed consent or assent (child) to the study, and provides signed authorization for use and disclosure of protected health information.

You may not qualify if…

• Any subject classified as "high risk" for exposure to avian or novel influenza, as determined by a Risk-Assessment Questionnaire.
• Subjects who had prior nasal wash/aspirate or nasopharyngeal wash/aspirate specimens collected for routine health-care purposes within the same suspected influenza infection episode.

Where it is running

• Naval Health Research Center — San Diego, California, United States
• Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
• John T Mather Hospital — Port Jefferson, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.